Literature DB >> 1903138

Vasoactive intestinal polypeptide nerve fibers in human and monkey (Macaca fascicularis and Macaca mulatta) kidneys.

J E Norvell1, R G MacBride, J Rowell.   

Abstract

Nerve fibers immunoreactive for vasoactive intestinal polypeptide (VIP) were demonstrated for the first time by the indirect immunofluorescence technique in human and monkey kidneys. VIP-immunoreactive nerve fibers showing varicosities were observed in the adventitia of arcuate arteries and their branches. The density of VIP-immunoreactive nerve fibers decreased from the juxtamedullary region to the cortex. Occasionally a VIP-immunoreactive varicose nerve fiber was observed near the vascular pole of a glomerulus, but no direct innervation of afferent or efferent arterioles in either monkey or human kidney was found. The distribution of VIP-immunoreactive nerve fibers in the monkey and human kidneys was similar to that reported in other species, with less density. The functional role of VIP in the innervation of the kidney is not known, but various suggestions have been made regarding the possible involvement of VIP on vasodilation of selective intrarenal blood vessels, renin secretion, and/or effects on tubules. While none of these questions were established at this time they would appear to be logical areas for further study.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903138     DOI: 10.1016/0165-1838(91)90060-g

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  2 in total

1.  Neuropeptide Levels as well as Neprilysin Activity Decrease in Renal Cell Carcinoma.

Authors:  Nuray Erin; Tümay İpekçi; Bahar Akkaya; İrem Hicran Özbudak; Mehmet Baykara
Journal:  Cancer Microenviron       Date:  2016-10-19

2.  Sympathetic innervation of the mouse kidney and liver arising from prevertebral ganglia.

Authors:  Hayden Torres; Clara Huesing; David H Burk; Adrien J R Molinas; Winfried L Neuhuber; Hans-Rudolf Berthoud; Heike Münzberg; Andrei V Derbenev; Andrea Zsombok
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-07-07       Impact factor: 3.210

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.